31![New drugs – necessity for therapeutic drug monitoring Stephan Krähenbühl Clinical Pharmacology & Toxicology University Hospital Basel New drugs – necessity for therapeutic drug monitoring Stephan Krähenbühl Clinical Pharmacology & Toxicology University Hospital Basel](https://www.pdfsearch.io/img/86e025f14357934a68006ce411ed7405.jpg) | Add to Reading ListSource URL: www.sulm.chLanguage: English - Date: 2013-10-23 12:25:48
|
---|
32![The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of medicinal products World Health The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of medicinal products World Health](https://www.pdfsearch.io/img/90a59d3210d2aea8240524a68ce5ed07.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2013-06-02 18:51:03
|
---|
33![](https://www.pdfsearch.io/img/c568f055d94d1d9aeb674943cf02c9be.jpg) | Add to Reading ListSource URL: media.wiley.comLanguage: English - Date: 2013-08-29 13:16:04
|
---|
34![Microsoft Word - ABFT Study Guide (December[removed]docx Microsoft Word - ABFT Study Guide (December[removed]docx](https://www.pdfsearch.io/img/3259a83a30dc450e793a98c696b8023d.jpg) | Add to Reading ListSource URL: abft.orgLanguage: English - Date: 2014-12-07 18:17:26
|
---|
35![Microsoft Word - ABFT Study Guide (December[removed]docx Microsoft Word - ABFT Study Guide (December[removed]docx](https://www.pdfsearch.io/img/5d6075b554b659b14d0a704b0b38388a.jpg) | Add to Reading ListSource URL: www.abft.orgLanguage: English - Date: 2014-12-07 18:17:26
|
---|
36![Abbott Medical Devices Overview Abbott is a world leader in developing and marketing innovation-driven medical devices for key therapeutic areas that have a significant impact on patients’ lives, including vascular dis Abbott Medical Devices Overview Abbott is a world leader in developing and marketing innovation-driven medical devices for key therapeutic areas that have a significant impact on patients’ lives, including vascular dis](https://www.pdfsearch.io/img/9cfd2ded53f764a03e069500bf264dfd.jpg) | Add to Reading ListSource URL: prod2.dam.abbott.comLanguage: English - Date: 2014-11-26 23:57:19
|
---|
37![The magnitude of personal financial interest: $0 - $10,000 per year Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical tr
The magnitude of personal financial interest: $0 - $10,000 per year Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical tr](https://www.pdfsearch.io/img/b54963c9cc40463e2587143a9107980d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
38![Disclaimer Statement The attached package contains background information prepared by the Food and Drug Administration (FDA) for the panel members of the advisory committee. The FDA background package might contain asses Disclaimer Statement The attached package contains background information prepared by the Food and Drug Administration (FDA) for the panel members of the advisory committee. The FDA background package might contain asses](https://www.pdfsearch.io/img/4a9deb92003fe66ecda124f89448f8e1.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
39![Guideline for measuring voriconazole concentrations Guideline for measuring voriconazole concentrations](https://www.pdfsearch.io/img/f823ba7b6a1cff5d52584cd76bc8a98d.jpg) | Add to Reading ListSource URL: www.hosp.uky.eduLanguage: English - Date: 2011-04-17 15:36:42
|
---|
40![article published online: 8 June 2014 | doi: [removed]nchembio.1554 Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring article published online: 8 June 2014 | doi: [removed]nchembio.1554 Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring](https://www.pdfsearch.io/img/7ed5a0e2426716a8a6a85026aacae7d7.jpg) | Add to Reading ListSource URL: www.bakerlab.orgLanguage: English - Date: 2014-11-26 05:31:48
|
---|